- Home
- ALIS vs IBIO Comparison
ALIS vs IBIO Comparison
Compare ALIS & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$1.65
Company Overview
Basic Information| Metric | ALIS | IBIO |
|---|---|---|
| Founded | 2024 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.9M | 72.2M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | ALIS | IBIO |
|---|---|---|
| Price | $9.98 | $1.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $4.75 |
| AVG Volume (30 Days) | 7.3K | ★ 938.8K |
| Earning Date | 01-01-0001 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.87 | $0.56 |
| 52 Week High | $10.07 | $4.69 |
Technical Indicators
Market Signals| Indicator | ALIS | IBIO |
|---|---|---|
| Relative Strength Index (RSI) | 46.95 | 31.82 |
| Support Level | $9.96 | $1.70 |
| Resistance Level | $10.03 | $1.81 |
| Average True Range (ATR) | 0.01 | 0.22 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 28.57 | 22.05 |
Price Performance
Historical Comparison ALIS
IBIO
About ALIS Calisa Acquisition Corp Ordinary shares
Calisa Acquisition Corp is a blank check company with the purpose of effecting a merger, asset acquisition, stock exchange, stock purchase, reorganization, or similar business combination.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.